About: Cytokines,eicosanoids and growth factors in the pathogenesis of primary glomerulonephritides

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Cytokines,eicosanoids and growth factors in the pathogenesis of primary glomerulonephritides Goto Sponge NotDistinct Permalink

An Entity of Type : http://linked.opendata.cz/ontology/domain/vavai/Projekt, within Data Space : linked.opendata.cz associated with source document(s)

Attributes	Values
rdf:type	http://linked.opendata.cz/ontology/domain/vavai/Projekt
rdfs:seeAlso	http://www.isvav.cz/projectDetail.do?rowId=NK4856
Description	The aim of the proposed study is to identify in patients with primapy glomerulopathies factors relating to the development of nephrotic syndrome and renal failure and compare the influence of enalapril and losarten on the progression of renal failure. (en) Identifikovat u nemocných s primárními glomerulopatiemi faktory,které mají vztah k vývoji nefrotického syndromu a renální insuficience a srovnat vliv enalaprilu a losartanu na progresi renální insuficience se snahou objasnit mechanismy event.rozdílů.
Title	Cytokines,eicosanoids and growth factors in the pathogenesis of primary glomerulonephritides (en) Cytokiny, eikosanoidy a růstové faktory v patogenezi primárních glomerulopatií
skos:notation	NK4856
http://linked.open...avai/cep/aktivita	Research and development in the other medical branches
http://linked.open...kovaStatniPodpora	http://linked.opendata.cz/resource/domain/vavai/projekt/NK4856/celkovaStatniPodpora
http://linked.open...ep/celkoveNaklady	http://linked.opendata.cz/resource/domain/vavai/projekt/NK4856/celkoveNaklady
http://linked.open...ep/duvernostUdaju	S - Úplné a pravdivé údaje nepodléhající ochraně podle zvláštních právních předpisů
http://linked.open.../cep/fazeProjektu	600873
http://linked.open...ai/cep/hlavniObor	FE - Ostatní obory vnitřního lékařství
http://linked.open...hodnoceniProjektu	V - Vynikající výsledky (s mezinárodním významem apod.). Zároveň byly splněny cíle a předpokládané výsledky uvedené ve smlouvě / rozhodnutí o poskytnutí podpory.
http://linked.open...ep/partnetrHlavni	Všeobecná fakultní nemocnice v Praze
http://linked.open...inujicichPrijemcu	0 (xsd:int)
http://linked.open...cep/pocetPrijemcu	1 (xsd:int)
http://linked.open...ocetSpoluPrijemcu	0 (xsd:int)
http://linked.open.../pocetVysledkuRIV	40 (xsd:int)
http://linked.open...enychVysledkuVRIV	40 (xsd:int)
http://linked.open...iciPoslednihoRoku	2001
http://linked.open...atUdajeProjZameru	2001
http://linked.open...usZobrazovaneFaze	DUU
http://linked.open...ai/cep/typPojektu	P - Projekt výzkumu a vývoje financovaný ze státního rozpočtu
http://linked.open...jektu+dodavatelem	Originální poznatky o významu cytokinů, eikosanoidů a některých růstových faktorů v rozvoji primárních glomerulopatií. Publikace: četné v domácím i zahraničním tisku Nephrology Dialysis Transplantation, Cardionephrology (cs)
http://linked.open...tniCyklusProjektu	ZBKU
is http://linked.open...vavai/riv/projekt of	Isoprostanes - new markers and mediators on oxidative stress. Ledviny a hypertenze. Losartan and enalapril in IgA nephropathy. Urinary IL-6/EGF ratio in ANCA-positive renal vasculitis, IgA nephropathy and lupus nephritis. The influence of losartan and enalapril on urinary excretion of 8-isoprostane in experimental nephrotic syndrome. Autoantigens and autoantibodies: Diagnistic Tools and Clue to understanding autoimmunity. Cardioxane-ICRF-187 protects from adriamycin-induced nephrotic syndrome. IgA nephropathy (IgAN) in the Czech Registry of renal biopsies (CRRB) in years 1995-1998. IgA nephropathy and oxidative stress during fish oil treatment. Farmakoterapie edémových stavů. Pharmacotherapy of the hypertension in renal disease. Hypertension and renal failure in a patient with haemolytic-uraemic syndrome. Can early treatment of renal anemia with erythropoietin decrease the high cardiovascular mortality of dialyzed patients? Repeated renal biopsy in patients with Wegeners granulomatosis and microscopic polyangiitis - contribution to prognosis and treatment. Renal and extrarenal production of cytokines in ANCA-positive vasculitis and lupus nephritis. Recurrent acute heart failure in Weeners granulomatosis. Quaternary Benzo/c/phenantridine alkaloids as inhibitors of dipeptidylpeptidase IV and aminopeptidase N. Urinary 8-isoprostane and IL-6/EGF in primary and secondary glomerulonephritides (ANCA-positive renal vasculitis, lupus nephritis, IgA nepropathy and membranous nepropathy). Trandolapril/verapamil in IgA nepropathy. ANCA - positive renal vasculitis - one centre experience (1) Antibodies against beta 2 - glycoprotein I in immunologically mediated renal diseases. ANCA-positive renal vasculitis - one centre experience. Antibodies against oxidized low density lipoproteins and phospholipids in patients with renal disorders. Angiotensin converting enzyme (ACE) polymorphism and the progression of autosomal dominant polycystic kidney disease (ADPKD) in Czech population. Endothelial nitric oxide synthase (ecNOS) affects the progression of autsomal dominant polycystic kidney disease. The Czech Society of Nephrology - An Introduction. Dipeptidyl Peptidase IV in Two Human Glioma Cell Lines of Different Phenotypeand Proliferation Properties. Long term treatment of IgA nephropathy with cyclosporine A. Long term treatment of IgA nephropathy with cyclosporine A - a preliminary report. Influence of the angiotensin converting enzyme (ACE) gene polymorphism in the progression of autosomal dominant polycystic kidney disease in Czech population. Are angiotensin II receptor blockers renoprotective? Léčba hypertenze u pacientů s renálním onemocněním. Long-term treatment of lupus nephritis with cyclosporine. Long-term treatment of lupus nephritis with cyclosporine. Long-term treatment of lupus nephritis with cyclosporine. Our experience with transjugular renal biopsy. Oxidative stress in IgA nephropathy during fish oil treatment. Specificity of antiphosphollipid antibodies in patients with renal diseases. Soluble adhesion molecules and cytokines in patients with myasthenia gravis treated by plasma exchange. Soluble TNF and IL-2 receptors in patients with breast cancer.
is http://linked.open...vavai/cep/projekt of	http://linked.opendata.cz/resource/domain/vavai/cep/ucast/NK4856/1998/ico%3A00064165 http://linked.opendata.cz/resource/domain/vavai/cep/ucast/NK4856/1999/ico%3A00064165 http://linked.opendata.cz/resource/domain/vavai/cep/ucast/NK4856/2000/ico%3A00064165 http://linked.opendata.cz/resource/domain/vavai/cep/ucast/NK4856/2001/ico%3A00064165

Faceted Search & Find service v1.16.116 as of Feb 22 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of Feb 22 2024, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (126 GB total memory, 82 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software